BioNTech SE is 4.6x more valuable than CG Oncology, Inc. by market capitalization ($22.18 B vs $4.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGON | BNTX |
|---|---|---|
| Market cap | $4.84 B | $22.18 B |
| US-listed rank | #1405 | #582 |
| Revenue (latest FY) | $4.04M | - |
| Net income (latest FY) | -$161.00M | - |
| Net margin | -3985.1% | - |
| SEC filings | 189 | 548 |
BioNTech SE is 4.6x more valuable than CG Oncology, Inc. by market capitalization ($22.18 B vs $4.84 B).
Full pages: CG Oncology, Inc. and BioNTech SE, or browse the full rankings.